Skip to content

Opening book details…

About this Medicine article

971 Preliminary results of a randomized study of 1 VS 2 910 MG/M/SQM doses of amifostine in high-RDI cyclophosphamide (CPM)-epirubicin (EDOX) in patients with high risk breast carcinoma by C. Cuvier; A. Ardavanis; J.M. Extra; M. Espie; W. Oster; M. Marty is a Medicine article available to read on EtoBox.

It is typically read by researchers, students, and practitioners in Medicine.

Author
C. Cuvier; A. Ardavanis; J.M. Extra; M. Espie; W. Oster; M. Marty
Publisher
Elsevier Science; Elsevier ; Elsevier Ltd.; Elsevier BV (ISSN 0959-8049)
Published
1995
Field
Medicine (Health Sciences)

More by C. Cuvier; A. Ardavanis; J.M. Extra; M. Espie; W. Oster; M. Marty

Browse all works by C. Cuvier; A. Ardavanis; J.M. Extra; M. Espie; W. Oster; M. Marty